Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma
NCT02500940 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2015-07-17
Summary
The purpose of this study is to investigate the impact of different neoadjuvant chemotherapy schedules of cisplatin and 5-FU on acute toxicity, tumor response, and long-term survival in patients with advanced nasopharyngeal carcinoma
Conditions
- Nasopharyngeal Carcinoma
Interventions
- DRUG
-
Neoadjuvant chemotherapy regimen with cisplatin
- DRUG
-
Neoadjuvant chemotherapy regimen with Fluorouracil
- RADIATION
-
Radiation therapy
Intensity-Modulated Radiation Therapy
- DRUG
-
Neoadjuvant chemotherapy regimen with Leucovorin
Sponsors & Collaborators
-
Fujian Cancer Hospital
collaborator OTHER_GOV -
Taichung Veterans General Hospital
lead OTHER
Principal Investigators
-
Lin Jin-Ching, Ph.D · Taichung Veterans General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2016-05-31
- Completion
- 2021-05-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT03427359 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial
NCT04502641 ·Status: UNKNOWN ·Phase: PHASE3
-
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
NCT02301208 ·Status: UNKNOWN ·Phase: PHASE3
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT05268614 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer
NCT01689194 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma
NCT04898374 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
NCT06455046 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence
NCT01142414 ·Status: WITHDRAWN ·Phase: PHASE3
-
Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT02143388 ·Status: COMPLETED ·Phase: PHASE3
-
Taxotere + Cisplatin in Nasopharyngeal Carcinoma
NCT00436293 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
NCT00004164 ·Status: UNKNOWN ·Phase: PHASE2
-
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
NCT04319471 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02778191 ·Status: COMPLETED
-
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer
NCT02901483 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma
NCT06490341 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma
NCT02360501 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC
NCT00997906 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NCT05050162 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
NCT06894459 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
NCT03623737 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
NCT06492460 ·Status: RECRUITING ·Phase: PHASE3
-
Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma
NCT07088484 ·Status: NOT_YET_RECRUITING
-
Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma
NCT01528618 ·Status: COMPLETED ·Phase: PHASE3
-
Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy
NCT03712397 ·Status: COMPLETED ·Phase: PHASE2
-
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT06136962 ·Status: NOT_YET_RECRUITING